EPISODE · May 9, 2018 · 11 MIN
Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma Inc. (OTCQB: TBPMF) - May'18 update
from Stock Day Media · host Stock Day Media
Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma Inc. (OTCQB: TBPMF)(TSXv: TBP), rejoins the show to give an update on the development of cannabis based prescription drugs and their clinical trials. OTCQB: TBPMF # TSXV: TBP # Aphria # IntelGenx Corp. # Dronabinol # Cannabis Research & Development # Aphria # Cannabis oil capsules # Guy Chamberland # Other Stocks # GRPOF Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma Inc. (OTCQB: TBPMF)(TSXv: TBP), rejoins the show to give an update on the development of cannabis based prescription drugs and their clinical trials. OTCQB: TBPMF # TSXV: TBP # Aphria # IntelGenx Corp. # Dronabinol # Cannabis Research & Development # Aphria # Cannabis oil capsules # Guy Chamberland # Other Stocks # GRPOF Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma Inc. (OTCQB: TBPMF) - May'18 update
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.